Log In
BCIQ
Print this Print this
 

Theravax HSV-2

  Manage Alerts
Collapse Summary General Information
Company Rational Vaccines Inc.
DescriptionLive-attenuated herpes simplex virus type 2 (HSV-2) ICP0- mutant virus based therapeutic vaccine
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPreclinical
Standard IndicationHerpes simplex virus (HSV)
Indication DetailsTreat herpes simplex virus type 2 (HSV-2) infection
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today